Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ubrelvy
Pharma
Judge sides with Lilly in patent case, overturning $177M verdict
A U.S. judge has sided with Lilly, overturning a $176.5M jury verdict awarded to Teva in a patent infringement squabble over competing migraine drugs.
Kevin Dunleavy
Sep 27, 2023 11:05am
Lilly finds stigma is one of the top problems for migraine
Jun 22, 2022 7:50am
AbbVie puts 'U' at the center of latest Ubrelvy TV ad
May 6, 2022 8:15am
AbbVie's migraine letdown sends chills down Biohaven's stock
May 2, 2022 9:12am
AbbVie runs first Qulipta TV ad spots
Feb 11, 2022 6:25am
Survey says: CGRP class set to grow, benefiting AbbVie, Biohaven
Jan 31, 2022 1:09pm